Drug General Information (ID: DDI26BFP9A)
  Drug Name Acetaminophen Drug Info Warfarin Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Analgesics Anticoagulants
  Structure

 Mechanism of Acetaminophen-Warfarin Interaction (Severity Level: Moderate)
     Increased risk of bleeding Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Acetaminophen Warfarin
      Mechanism Risk of bleeding
Antiplatelet effects 
Risk of bleeding
Anticoagulant 
      Key Mechanism Factor 1
Factor Name Bleeding
Factor Description Patients may be at risk for bleeding when the outcome of a disease or disease treatment confounds the standard mechanisms for maintaining hemostasis. Signs or symptoms of abnormal bleeding include: bleeding that takes a long time to stop (including nosebleeds, bleeding gums, bleeding from cuts and abrasions, and menstrual bleeding); severe unexplained bruising, or bruising that becomes larger; blood in the urine or stool, etc.
      Mechanism Description
  • Increased risk of bleeding by the combination of Acetaminophen and Warfarin 

Recommended Action
      Management Due to the lack of safer alternatives, acetaminophen is considered the analgesic and antipyretic drug of choice for patients receiving warfarin and similar anticoagulants. However, caution is recommended during concomitant therapy, particularly if high dosages of APAP are used continuously for more than a few days, or in patients with risk factors such as ethanol consumption, old age, and malnutrition. Closer monitoring of INR may be advisable. Patients should be advised to promptly report any signs of bleeding to their physician, including pain, swelling, headache, dizziness, weakness, prolonged bleeding from cuts, increased menstrual flow, vaginal bleeding, nosebleeds, bleeding of gums from brushing, unusual bleeding or bruising, red or brown urine, or red or black stools.

References
1 Antlitz AM, Mead JA Jr, Tolentino MA "Potentiation of oral anticoagulant therapy by acetaminophen." Curr Ther Res Clin Exp 10 (1968): 501-7. [PMID: 4971464]
2 Bagheri H, Bernhard NB, Montastruc JL "Potentiation of the acenocoumarol anticoagulant effect by acetaminophen." Ann Pharmacother 33 (1999): 506. [PMID: 10332548]
3 Bell RB "Acetaminophen and warfarin: undesirable synergy." JAMA 279 (1998): 702-3. [PMID: 9496990]
4 Boeijinga JJ, Boerstra EE, Ris P, Breimer DD, Jeletich-Bastiaanse A "Interaction between paracetamol and coumarin anticoagulants." Lancet 1 (1982): 506. [PMID: 6121161]
5 Gebauer MG, Nyfort-Hansen K, Henschke PJ, Gallus AS "Warfarin and acetaminophen interaction." Pharmacotherapy 23 (2003): 109-12. [PMID: 12523469]
6 Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE "Acetaminophen and other risk factors for excessive warfarin anticoagulation." JAMA 279 (1998): 657-62. [PMID: 9496982]
7 Kwan D, Bartle WR, Walker SE "The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin." J Clin Pharmacol 39 (1999): 68-75. [PMID: 9987702]
8 Shek KL, Chan LN, Nutescu E "Warfarin-acetaminophen drug interaction revisited." Pharmacotherapy 19 (1999): 1153-8. [PMID: 10512064]
9 Singer DE, Skates SJ "Acetaminophen and risk factors for excess anticoagulation with warfarin." JAMA 281 (1999): 37. [PMID: 9728633]
10 Wells PS, Holbrook AM, Crowther NR, Hirsh J "Interactions of warfarin with drugs and food." Ann Intern Med 121 (1994): 676-83. [PMID: 7944078]
11 Fattinger K, Frisullo R, Masche U, Braunschweig S, Meier PJ, Roos M "No clinically relevant drug interaction between paracetamol and phenprocoumon based on a pharmacoepidemiological cohort study in medical inpatients." Eur J Clin Pharmacol 57 (2002): 863-7. [PMID: 11936705]